Sign inJoin waitlistJoin the waitlist

RF

Richard Fisher

Physician · Lewis Katz School of Medicine at Temple University

Credentials: · · · ·

History

Lewis Katz School of Medicine at Temple University
2021–Present

Hematology and Medical Oncology
1973–1976
Internal Medicine
1970–1973
Harvard Medical School
1966–1970

Research

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification
Journal of Clinical Oncology · 2014 · 4,572 citations
Revised response criteria for malignant lymphoma
Journal of Clinical Oncology · 2007 · 3,875 citations
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group
Review · Journal of Clinical Oncology · 1999 · 3,123 citations

Jonathan Friedberg
48 papers
TM
Thomas Miller
38 papers
Lisa Rimsza
35 papers
Elaine Jaffe
30 papers
Julie Vose
26 papers
BC
Bruce Cheson
23 papers
TG
Thomas Grogan
23 papers
VD
Vincent DeVita
22 papers
EG
Ellen Gaynor
21 papers
GW
Geoffrey Weiss
19 papers
Kim Margolin
19 papers
PS
Patrick Stiff
19 papers

Grants

Comprehensive Cancer Center Program at Fox Chase
National Cancer Institute · P30
Contact PI · $25.8M · Research Inst of Fox Chase Can Ctr
1997–2022
Southwest Oncology Group
National Cancer Institute · U10
Contact PI · $3.9M · University of Rochester
1978–2015
SPORE in Lymphoma
National Cancer Institute · P50
Contact PI · $9.7M · University of Rochester
2008–2014
Southwest Oncology Group
National Cancer Institute · U10
Contact PI · $3.5M · Loyola University Chicago
1988–2003

Clinical trials

S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
Study chair · Completed · Phase 2
SWOG Cancer Research Network
2006–2017
SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Study chair · Completed
SWOG Cancer Research Network
2005–2011
S0433 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
Study director · Completed · Phase 2
SWOG Cancer Research Network
2005–2015